Bio News
-
Bio News | Breaking News | Drug Development | Drug Discovery | Facilities | Industry News | Laboratory Testing | R&D
PolyU, Axis Therapeutics Partner for Immunotherapy
The joint immunotherapy center will aim to conduct collaborative research on cancer immunotherapy in Hong KongVideos
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Galapagos and MorphoSys Partner with Novartis
Novartis will cover development and commercialization costs of their joint program, MOR10607.19.18
-
Bio News | Industry News | Logistics | Packaging & Tracking | Supply Chain
TrakCel, Mustang Ink Supply Chain Deal
Companies aim to build a custom-configured cellular supply chain tracking and orchestration platform07.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Kite, Gadeta Enter Collaboration
To develop novel gamma delta TCR therapies in various cancers07.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Innovest Global Launches Biotech Division
With the acquisition of a 20% interest in StemVax Therapeutics, who is currently developing a cancer vaccine therapy07.18.18
-
Bio News | Breaking News | Industry News | Trials & Filings
Roche's Tecentriq Granted Breakthrough Therapy Designation
For Tecentriq in combination with Avastin as an initial treatment for people with liver cancer07.18.18
-
Bio News | Breaking News | Industry News | Logistics | Packaging & Tracking
Cryoport, World Courier Ink Logistics Deal
Cryoport’s full suite of temperature-controlled solutions will be integrated into World Courier's global network07.17.18
-
Bio News | Clinical Trials | Industry News | R&D
Roche Phase III Study Meets Primary Objective
Assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu07.17.18
-
Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News | R&D
Institut Pasteur Installs Thermo Scientific Krios Cryo-TEM
Will allow structural biologists at the Institut Pasteur to extend their research in areas such as immunology & bacteriology07.13.18
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | Trials & Filings
Amgen, UCB Resubmit BLA
For EVENITY for the treatment of osteoporosis in postmenopausal women at high risk for fracture07.13.18
-
Bio News | Clinical Trial Materials | Collaborations & Alliances | Industry News
VWR, E&I Sign Contract
Five-year laboratory supplies and services contract was awarded to VWR after an extensive competitive RFP process07.13.18
-
Analytical Services | Bio News | Breaking News | Clinical Trials | CRO News | Drug Discovery | Laboratory Testing
Streamlining the Clinical Process
Richard Young, vice president at Veeva, shares insight on what companies can do to further expedite the clinical processOnline Exclusives07.12.18
-
Bio News | Breaking News | Drug Development | Industry News
Akebia Therapeutics & Keryx Biopharmaceuticals Merge
John P. Butler to be president and chief executive of combined company07.12.18
-
Bio News | Breaking News | Drug Development | Industry News
Otsuka Buying Visterra for $430M
Hierotope platform enables design and engineering of next-generation antibody-based therapies07.12.18
-
Bio News | Collaborations & Alliances | Drug Delivery | Industry News
VIDEO: DuPont, SkyCell Form Alliance
Partnership focuses on maintaining the physical and clinical integrity of pharmaceuticals in transit07.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Immatics & Genmab Enter Collaboration
To develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications07.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Gyros, Cygnus Sign Agreement
To enable the development of new Gyrolab immunoassay kits to further support customers working in biotherapeutics development07.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Trials & Filings
Selexis, Symphogen Expand Partnership
Under the terms of an earlier license agreement, Symphogen has opened two INDs for clinical programs utilizing Selexis’ SGE07.11.18
-
Bio News | cGMP Manufacture | Facilities | Industry News
Lifeline Cell Technology Expands Capabilities
Upgrades made in all operational departments, including new equipment for the handling of quadruple its original batch size07.10.18
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Filament BioSolutions, Ajinomoto in Devt. Collaboration
Filament is expanding its product pipeline to include multiple oncology co-therapies07.10.18
